Multifunctional calcium phosphate nanoparticles for combining near-infrared fluorescence imaging and photodynamic therapy

Acta Biomaterialia

Volumn 14, Issue , 2015, Pages 197-207

  Haedicke, Katja ^a   Kozlova, Diana ^b   Gräfe, Susanna ^c   Teichgräber, Ulf ^a   Epple, Matthias ^b   Hilger, Ingrid ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c Biolitec Research GmbH   (Germany)

Author keywords

Apoptosis; Calcium phosphate nanoparticles; NIRF optical imaging; Photodynamic therapy; Vascularization

Indexed keywords

CALCIUM PHOSPHATE; CELL DEATH; FLUORESCENCE IMAGING; INFRARED DEVICES; MAMMALS; NANOPARTICLES; OPTICAL IMAGE STORAGE; PHOTOSENSITIZERS; TUMORS;

CALCIUM PHOSPHATE NANOPARTICLES; FLUORESCENCE OPTICAL IMAGING; NEAR-INFRARED FLUORESCENCE; NEAR-INFRARED FLUORESCENCE IMAGING; NEAR-INFRARED FLUORESCENCE OPTICAL IMAGING; PHOTOSENSITISER; THERAPEUTIC EFFICACY; TUMOR VASCULARIZATION; TUMOR-TARGETING; VASCULARIZATION;

PHOTODYNAMIC THERAPY;

ARGINYLGLYCYLASPARTIC ACID; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE NANOPARTICLE; CYCLO(ARGINYLGLYCYLASPARTYLPHENYLALANYLLYSINE); DRUG CARRIER; DY 682 N HYDROXYSUCCINIMIDYL ESTER; SUCCINIMIDE DERIVATIVE; TEMOPORFIN; UNCLASSIFIED DRUG; ARGINYL-GLYCYL-ASPARTIC ACID; NANOPARTICLE; OLIGOPEPTIDE;

ABSORPTION SPECTROSCOPY; ANIMAL CELL; APOPTOSIS; ARTICLE; ENDOTHELIUM CELL; FEMALE; FLUORESCENCE IMAGING; FLUORESCENCE IMAGING SYSTEM; HYDRODYNAMICS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEAR INFRARED FLUORESCENCE IMAGING; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TARGET CELL; THERAPY EFFECT; TUMOR REGRESSION; TUMOR VASCULARIZATION; TUMOR VOLUME; ANIMAL; DIAGNOSTIC USE; DRUG EFFECTS; ENDOCYTOSIS; FLUORESCENCE; HUMAN; INFRARED RADIATION; LIGHT; LUMINESCENCE; MOLECULAR IMAGING; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NUDE MOUSE; PATHOLOGY; PHOTOCHEMOTHERAPY; PROCEDURES; RADIATION SCATTERING; TISSUE DISTRIBUTION; TUMOR CELL LINE; ULTRASTRUCTURE; VASCULARIZATION;

MUS;

ANIMALS; APOPTOSIS; CALCIUM PHOSPHATES; CELL LINE, TUMOR; ENDOCYTOSIS; FEMALE; FLUORESCENCE; HUMANS; INFRARED RAYS; LIGHT; LUMINESCENT MEASUREMENTS; MICE, NUDE; MOLECULAR IMAGING; NANOPARTICLES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OLIGOPEPTIDES; PHOTOCHEMOTHERAPY; SCATTERING, RADIATION; TISSUE DISTRIBUTION;

EID: 84921847078     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2014.12.009     Document Type: Article

References (54)

1. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin 2011;61:250-81.
2. Allison RR, Sibata CH. Oncologic photodynamic therapy photosensitizers: a clinical review. Photodiagnosis Photodyn Ther 2010;7:61-75.
3. de Visscher SA, Dijkstra PU, Tan IB, Roodenburg JL, Witjes MJ. MTHPC mediated photodynamic therapy (PDT) of squamous cell carcinoma in the head and neck: a systematic review. Oral Oncol 2013;49:192-210.
4. Mannino S, Molinari A, Sabatino G, Ciafre SA, Colone M, Maira G, et al. Intratumoral vs systemic administration of meta-tetrahydroxyphenylchlorin for photodynamic therapy of malignant gliomas: assessment of uptake and spatial distribution in C6 rat glioma model. Int J Immunopathol Pharmacol 2008;21:227-31.
5. Shieh MJ, Peng CL, Chiang WL, Wang CH, Hsu CY, Wang SJJ, et al. Reduced skin photosensitivity with meta-tetra(hydroxyphenyl)chlorin-loaded micelles based on a poly(2-ethyl-2-oxazoline)-b-poly(D,L-lactide) diblock copolymer in vivo. Mol Pharm 2010;7:1244-53.
6. Shirasu N, Nam SO, Kuroki M. Tumor-targeted photodynamic therapy. Anticancer Res 2013;33:2823-31.
7. Sibani SA, McCarron PA, Woolfson AD, Donnelly RF. Photosensitiser delivery for photodynamic therapy. Part 2. Systemic carrier platforms. Expert Opin Drug Deliv 2008;5:1241-54.
8. Jia X, Jia L. Nanoparticles improve biological functions of phthalocyanine photosensitizers used for photodynamic therapy. Curr Drug Metab 2012;13:1119-22.
9. Tacelosky DM, Creecy AE, Shanmugavelandy SS, Smith JP, Claxton DF, Adair JH, et al. Calcium phosphosilicate nanoparticles for imaging and photodynamic therapy of cancer. Discovery Med 2012;13:275-85.
10. Wang C, Cheng L, Liu Z. Upconversion nanoparticles for photodynamic therapy and other cancer therapeutics. Theranostics 2013;3:317-30.
11. Park K, Lee S, Kang E, Kim K, Choi K, Kwon IC. New generation of multifunctional nanoparticles for cancer imaging and therapy. Adv Funct Mater 2009;19:1553-66.
12. Singh AK, Hahn MA, Gutwein LG, Rule MC, Knapik JA, Moudgil BM, et al. Multidye theranostic nanoparticle platform for bioimaging and cancer therapy. Int J Nanomed 2012;7:2739-50.
13. Asghari S, Johari SA, Lee JH, Kim YS, Jeon YB, Choi HJ, et al. Toxicity of various silver nanoparticles compared to silver ions in Daphnia magna. J Nanobiotechnol 2012;10:11.
14. Huang P, Li Z, Lin J, Yang D, Gao G, Xu C, et al. Photosensitizer-conjugated magnetic nanoparticles for in vivo simultaneous magnetofluorescent imaging and targeting therapy. Biomaterials 2011;32:3447-58.
15. Accardo A, Tesauro D, Morelli G. Peptide-based targeting strategies for simultaneous imaging and therapy with nanovectors. Polym J 2013;45:481-93.
16. Kozlova D, Epple M. Biological targeting with nanoparticles: state of the art. BioNanoMat 2013;14:161-70.
17. Chen H, Zhen Z, Tang W, Todd T, Chuang YJ, Wang L, et al. Label-free luminescent mesoporous silica nanoparticles for imaging and drug delivery. Theranostics 2013;3:650-7.
18. Rangger C, Helbok A, von Guggenberg E, Sosabowski J, Radolf T, Prassl R, et al. Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles. Int J Nanomed 2012;7:5889-900.
19. Rangger C, Helbok A, Sosabowski J, Kremser C, Koehler G, Prassl R, et al. Tumor targeting and imaging with dual peptide conjugated multifunctional liposomal nanoparticles. Int J Nanomed 2013;8:4659-71.
20. Strijkers GJ, Kluza E, Van Tilborg GA, van der Schaft DW, Griffioen AW, Mulder WJ, et al. Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis. Angiogenesis 2010;13:161-73.
21. Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol 2001;19:316-7.
22. Luo S, Zhang E, Su Y, Cheng T, Shi C. A review of NIR dyes in cancer targeting and imaging. Biomaterials 2011;32:7127-38.
23. Quek C-H, Leong KW. Near-infrared fluorescent nanoprobes for in vivo optical imaging. Nanomaterials 2012;2:92-112.
24. Merian J, Gravier J, Navarro F, Texier I. Fluorescent nanoprobes dedicated to in vivo imaging: from preclinical validations to clinical translation. Molecules 2012;17:5564-91.
25. Padilla Mondejar S, Kovtun A, Epple M. Lanthanide-doped calcium phosphate nanoparticles with high internal crystallinity and with a shell of DNA as fluorescent probes in cell experiments. J Mater Chem 2007;17:4153-9.
26. Kester M, Heakal Y, Fox T, Sharma A, Robertson GP, Morgan TT, et al. Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells. Nano Lett 2008;8:4116-21.
27. Guo Y, Shi D, Lian J, Dong Z, Wang W, Cho H, et al. Quantum dot conjugated hydroxylapatite nanoparticles for in vivo imaging. Nanotechnology 2008;19:175102-8.
28. Morgan TT, Muddana HS, Altinoglu EI, Rouse SM, Tabakovic A, Tabouillot T, et al. Encapsulation of organic molecules in calcium phosphate nanocomposite particles for intracellular imaging and drug delivery. Nano Lett 2008;8:4108-15.
29. Min KH, Lee HJ, Kim K, Kwon IC, Jeong SY, Lee SC. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles. Biomaterials 2012;33:5788-97.
30. Sokolova VV, Radtke I, Heumann R, Epple M. Effective transfection of cells with multi-shell calcium phosphate-DNA nanoparticles. Biomaterials 2006;27:3147-53.
31. Zhang X, Kovtun A, Mendoza-Palomares C, Oulad-Abdelghani M, Facca S, Fioretti F, et al. SiRNA-loaded multi-shell nanoparticles incorporated into a multilayered film as a reservoir for gene silencing. Biomaterials 2010;31:6013-8.
32. Epple M, Ganesan K, Heumann R, Klesing J, Kovtun A, Neumann S, et al. Application of calcium phosphate nanoparticles in biomedicine. J Mater Chem 2010;20:18-23.
33. Altinoʇlu EI. Indocyanine green-encapsulating calcium phosphosilicate nanoparticles: bifunctional theranostic vectors for near infrared diagnostic imaging and photodynamic therapy [Ph.D. thesis]. The Pennsylvania State University; 2010.
34. Kozlova D, Chernousova S, Knuschke T, Buer J, Westendorf AM, Epple M. Cell targeting by antibody-functionalized calcium phosphate nanoparticles. J Mater Chem 2012;22:396-404.
35. Barth BM, Sharma R, Altinoglu EI, Morgan TT, Shanmugavelandy SS, Kaiser JM, et al. Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo. ACS Nano 2010;4:1279-87.
36. Klesing J, Wiehe A, Gitter B, Gräfe S, Epple M. Positively charged calcium phosphate/polymer nanoparticles for photodynamic therapy. J Mater Sci Mater Med 2010;21:887-92.
37. Schwiertz J, Wiehe A, Gräfe S, Gitter B, Epple M. Calcium phosphate nanoparticles as efficient carriers for photodynamic therapy against cells and bacteria. Biomaterials 2009;30:3324-31.
38. Barth BM, Altinoʇlu EI, Shanmugavelandy SS, Kaiser JM, Crespo-Gonzalez D, DiVittore NA, et al. Targeted indocyanine-green-loaded calcium phosphosilicate nanoparticles for in vivo photodynamic therapy of leukemia. ACS Nano 2011;5:5325-37.
39. Klesing J, Chernousova S, Epple M. Freeze-dried cationic calcium phosphate nanorods as versatile carriers of nucleic acids (DNA, siRNA). J Mater Chem 2012;22:199-204.
40. Haedicke K, Grafe S, Lehmann F, Hilger I. Multiplexed in vivo fluorescence optical imaging of the therapeutic efficacy of photodynamic therapy. Biomaterials 2013;34:10075-83.
41. Urch H, Vallet-Regi M, Ruiz L, Gonzalez-Calbet JM, Epple M. Calcium phosphate nanoparticles with adjustable dispersability and crystallinity. J Mater Chem 2009;19:2166-71.
42. Mathews AS, Ahmad S, Shahin M, Lavasanifar A, Kaur K. Peptide modified polymeric micelles specific for breast cancer cells. Bioconjugate Chem 2013;24:560-70.
43. Fu L, Tang J, Shi K, Chen W, Zhang Q, He Q. Dual-ligand liposomes containing RGD and TAT for enhanced cell selectivity and internalization. Asian J Pharm Sci 2012;7:225-9.
44. Kossatz S, Behe M, Mansi R, Saur D, Czerney P, Kaiser WA, et al. Multifactorial diagnostic NIR imaging of CCK2R expressing tumors. Biomaterials 2013;34:5172-80.
45. Hamann FM, Brehm R, Pauli J, Grabolle M, Frank W, Kaiser WA, et al. Controlled modulation of serum protein binding and biodistribution of asymmetric cyanine dyes by variation of the number of sulphonate groups. Mol Imaging 2011;10:258-69.
46. Botella P, Abasolo I, Fernandez Y, Muniesa C, Miranda S, Quesada M, et al. Surface-modified silica nanoparticles for tumor-targeted delivery of camptothecin and its biological evaluation. J Control Release 2011;156:246-57.
47. Martins SM, Sarmento B, Nunes C, Lucio M, Reis S, Ferreira DC. Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration. Eur J Pharm Biopharm 2013;85:488-502.
48. Shenoy D, Little S, Langer R, Amiji M. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. Part 2. In vivo distribution and tumor localization studies. Pharm Res 2005;22:2107-14.
49. Xie G, Sun J, Zhong G, Shi L, Zhang D. Biodistribution and toxicity of intravenously administered silica nanoparticles in mice. Arch Toxicol 2010;84:183-90.
50. Zhang JS, Liu F, Huang L. Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity. Adv Drug Deliv Rev 2005;57:689-98.
51. Dolmans DE, Kadambi A, Hill JS, Flores KR, Gerber JN, Walker JP, et al. Targeting tumor vasculature and cancer cells in orthotopic breast tumor by fractionated photosensitizer dosing photodynamic therapy. Cancer Res 2002;62:4289-94.
52. Garrier J, Bressenot A, Grafe S, Marchal S, Mitra S, Foster TH, et al. Compartmental targeting for mTHPC-based photodynamic treatment in vivo: correlation of efficiency, pharmacokinetics, and regional distribution of apoptosis. Int J Radiat Oncol Biol Phys 2010;78:563-71.
53. Lassalle HP, Dumas D, Grafe S, D'Hallewin MA, Guillemin F, Bezdetnaya L. Correlation between in vivo pharmacokinetics, intratumoral distribution and photodynamic efficiency of liposomal mTHPC. J Control Release 2009;134:118-24.
54. Low PS, Kularatne SA. Folate-targeted therapeutic and imaging agents for cancer. Curr Opin Chem Biol 2009;13:256-62.